![](/img/cover-not-exists.png)
First‐Line Palliative HER2‐Targeted Therapy in HER2‐Positive Metastatic Breast Cancer Is Less Effective After Previous Adjuvant Trastuzumab‐Based Therapy
Rier, Hánah N., Levin, Mark‐David, van Rosmalen, Joost, Bos, Monique M. E. M., Drooger, Jan C., de Jong, Paul, Portielje, Johanneke E. A., Elsten, Elisabeth M. P., Ten Tije, Albert‐Jan, Sleijfer, StefLanguage:
english
Journal:
The Oncologist
DOI:
10.1634/theoncologist.2016-0448
Date:
May, 2017
File:
PDF, 440 KB
english, 2017